BECN1 and Parkinson disease: Gene-transfer induced overexpression of Beclin-1 was able to reduce accumulation of α-syn in α-syn overexpressing mice [137] and PC12 cells [138], suggesting that the Beclin-1 pathway may be a viable therapeutic target in PD.